Correlation Between Evogene and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evogene and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Evogene and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Eupraxia Pharmaceuticals.
Diversification Opportunities for Evogene and Eupraxia Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Evogene and Eupraxia is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Evogene i.e., Evogene and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evogene and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Evogene is expected to under-perform the Eupraxia Pharmaceuticals. In addition to that, Evogene is 1.21 times more volatile than Eupraxia Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Eupraxia Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest 297.00 in Eupraxia Pharmaceuticals on November 4, 2024 and sell it today you would lose (18.00) from holding Eupraxia Pharmaceuticals or give up 6.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 66.67% |
| Values | Daily Returns |
Evogene vs. Eupraxia Pharmaceuticals
Performance |
| Timeline |
| Evogene |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Evogene and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Evogene and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |